Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582751 · ClinicalTrials.gov registry record
Volumetric Analysis in the Assessment of Therapy Response by CT
A clinical trial of Multiple Diseases, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT00582751 is a study of Multiple Diseases that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00582751, a study of Multiple Diseases, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the volumetric response achieved using semi-automated computer techniques with the uni-dimensional (RECIST) and bi-dimensional (WHO) criteria as part of clinical trials running at MSKCC, testing new agents for different types of solid tumors.
Conditions Studied
Study Locations (1)
New York
- Memorial Sloan-Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582751
The ClinicalTrials.gov registry entry for NCT00582751 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00582751 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00582751 about?
NCT00582751 is a clinical study titled "Volumetric Analysis in the Assessment of Therapy Response by CT". To compare the volumetric response achieved using semi-automated computer techniques with the uni-dimensional (RECIST) and bi-dimensional (WHO) criteria as part of clinical trials running at MSKCC, testing new agents for different types of solid tumors.
What is the current status of trial NCT00582751?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2007-11. Estimated completion is 2010-11.
What conditions does trial NCT00582751 study?
This clinical trial studies the following conditions: Multiple Diseases.
Who is sponsoring clinical trial NCT00582751?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00582751 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.